Metadata
- Name
- First in Human Study of KO-539 in Relapsed or Refractory Acute Myeloid Leukemia
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT04067336
- Description
- This first-in-human (FIH) dose-escalation and dose-validation/expansion study will assess
KO-539, a menin-MLL(KMT2A) inhibitor, in patients with refractory or relapsed acute myeloid
leukemia (AML). - Data or Study Types
- clinical trial
- Keywords
- Acute Leukemia, Leukemia, Menin, MLLr, KMT2A, Hematological malignancy, NPM1, AML
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2019
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT04067336
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT04067336